Annals of Epidemiology
Volume 20, Issue 4 , Pages 289-297 , April 2010

Associations Between Duration of Illicit Drug Use and Health Conditions: Results from the 2005–2007 National Surveys on Drug Use and Health

Received 28 July 2009 ,Accepted 6 January 2010.

References 

  1. Polen MR, Sidney S, Tekawa IS, Sadler M, Friedman GD. Health care use by frequent marijuana use smokers who do not smoke tobacco. West J Med. 1993;158:596–601
  2. Hollister LE. Health aspects of cannabis. Pharmacol Rev. 1986;38:1–20
  3. Tashkin DP. Pulmonary complications of smoked substance abuse. West J Med. 1990;152:525–530
  4. Mittleman MA, Lewis RA, Maclure M, Sherwood JB, Muller JE. Triggering myocardial infarction by marijuana. Circulation. 2001;102:2805–2809
  5. Khalsa JH, Genser S, Francis H, Martin B. Clinical consequences of marijuana. J Clin Pharmacol. 2002;42(11 Suppl):7s–10s
  6. Klein TW, Friedman H, Specter S. Marijuana, immunity and infection. J Neuroimmunol. 1998;83:102–115
  7. Cregler LL, Mark H. Medical complications of cocaine abuse. N Engl J Med. 1986;315:1495–1500
  8. Schindler CW, Goldberg SR. Cardiovascular effects of cocaine: underlying mechanisms. Drug Alcohol Depend. 1995;37:181–182
  9. Hollander J. The management of cocaine-associated myocardial ischemia. N Engl J Med. 1995;333:1267–1272
  10. Fessker RD, Esshaki CM, Stankewitz RC, Johnson RR, Diaz FG. The neurovascular complications of cocaine. Surg Neurol. 1997;47:339–345
  11. Mello NK, Mendelson JH. Cocaine's effects on neuroendocrine systems: clinical and preclinical studies. Pharmacol Biochem Behav. 1997;57:571–599
  12. Chen K, Scheier LM, Kandel DB. Effects of chronic cocaine use on physical health: a prospective study in a general population sample. Drug Alcohol Depend. 1996;43:23–37
  13. Reichlin S. Neuroendocrine-endocrine-immune interactions. N Engl J Med. 1993;329:1246–1253
  14. Friedman LN, Williams MT, Singh TP, Frieden TR. Tuberculosis, AIDS, and death among substance abusers on welfare in New York city. N Engl J Med. 1996;334:828–833
  15. Theodorou S, Haber PS. The medical complications of heroin use. Curr Opin Psychiatry. 2005;18:257–263
  16. Garten RJ, Lai S, Zhang J. Rapid transmission of hepatitis C virus among young injecting heroin users in southern China. Int J Epidemiol. 2004;33:182–188
  17. Everall IP. Interaction between HIV and intravenous heroin abuse?. J Neuroimmunol. 2004;147:13–15
  18. Buttner A, Mall G, Penning R, Weis S. The neuropathology of heroin abuse. Forensic Sci Int. 2000;113:435–442
  19. Rodgers J, Buchanan T, Pearson C, Parrott AC, Ling J, Hefferman TM, et al. Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study. J Psychopharmacol. 2006;20:437–446
  20. Aghajanian GK, Marek GJ. Serotonin and hallucinogens. Neuropsychopharmacology. 1999;21:16S–23S
  21. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301–1308
  22. National Institute on Drug Abuse (NIDA). NIDA InfoFacts: Hallucinogens-LSD, Peyote, Psilocybin, and PCP. Available at: http://www.nida.nih.gov/infofacts/hallucinogens.html. Accessed December 1, 2008.
  23. Halpern JH, Pope HG. Do hallucinogens cause residual neuropsychological toxicity?. Drug Alcohol Depend. 1999;53:247–256
  24. Acord LD, Barker DD. Hallucinogenic drugs and cerebral deficit. J Nerv Ment Dis. 1973;156:281–283
  25. Culver CM, King FW. Neuropsychological assessment of undergraduate marijuana and LSD users. Arch Gen Psychiatry. 1974;31:707–711
  26. Ridenour TA. Inhalants: Not to be taken lightly anymore. Curr Opin Psychiatry. 2005;18:243–247
  27. Medina-Mora ME, Real T. Epidemiology of inhalant use. Curr Opin Psychiatry. 2008;21:247–251
  28. Freedenthal S, Vaughn MG, Jenson JM, Howard MO. Inhalant use and suicidality among incarcerated youth. Drug Alcohol Depend. 2007;90:81–88
  29. Soderberg LS. Immunomodulation by nitrite inhalants may predispose abusers to AIDS and Kaposi's sarcoma. J Neuroimmunol. 1998;83:157–161
  30. Buchbinder SP, Vittinghoff E, Heagerty PJ, Celum CL, Seage GR, Judson FN, et al. Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2005;39:82–89
  31. Macleod J, Oaks R, Copello A, Crome I, Egger M, Hickman M, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet. 2004;363:1579–1588
  32. Resnick MD, Bearman PS, Blum RW, Bauman KE, Harris KM, Jones J, et al. Protecting adolescents from harm: findings from the National Longitudinal Study on Adolescent Health. JAMA. 1997;278:823–832
  33. Dornbusch SM, Lin I-C, Munroe PT, Bianchi AJ. Adolescent polydrug use and violence in the United States. Int J Adolesc Med Health. 1999;11:197–219
  34. Kaesner R. New estimates of the effect of marijuana and cocaine use on wages. Indust Labor Relat Rev. 1994;47:454–470
  35. Greenwell L, Brecht M. Self-reported health status among treated methamphetamine users. Am J Drug Alcohol Abuse. 2003;29:75–104
  36. Spinks R, Caspers K, Langbehn D, Yucuis R, McKirgan LW, Arndt S, et al. Co-morbid health conditions at mid-life in the Iowa adoptees. Addict Behav. 2007;32:991–1002
  37. Adrian M, Barry SJ. Physical and mental health problems associated with the use of alcohol and drugs. Subst Use Misuse. 2003;38:1575–1614
  38. National Institute on Drug Abuse (NIDA): Commonly abused drugs chart. Available at the NIDA web site: http://www.drugabuse.gov/DrugPages/DrugsofAbuse.html. Accessed April 1, 2009.
  39. American Council for Drug Education (ACDE). Basic facts about drugs: Alcohol. Available at the ACDE web site: http://www.acde.org/common/alcohol.htm. Accessed April 1, 2009.
  40. American Council for Drug Education (ACDE). Start with the fact: Tobacco. Available at the ACDE website: http://www.acde.org/common/Tobacco%202002.pdf. Accessed April 1, 2009.
  41. U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004;
  42. Rehm J, Graham K, Monteiro M, Gmel G, Sempos CT. The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview. Addiction. 2003;98:1209–1228
  43. Alderdice FA, Davidson R. The effect of alcohol consumption on recency discrimination ability: an early screening test for alcohol-induced cognitive impairment. Br J Addict. 1990;85:531–536
  44. Harper CG, Kril JJ. Neuropathology of alcoholism. Alcohol Alcohol. 1990;25:207–216
  45. Reid MC, Fiellin DA, O'Connor PG. Hazardous and harmful alcohol consumption in primary care. Arch Intern Med. 1999;159:1681–1689
  46. Tenth Special Report to the United States Congress on Alcohol and Health. Medical consequences of alcohol abuse. Alcohol Research and Health. 2000;24:27–31
  47. Cornfield J, Haenszel W, Hammond EC, Lilienfeld AM, Shimkin MB, Wynder EL. Smoking and lung cancer: recent evidence and a discussion of some questions. J Natl Cancer Inst. 1959;22(1):173–203
  48. National Cancer Institute. Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control. Smoking and Tobacco Control Monograph No. 8. Bethesda (MD): U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 1997;NIH Publication No. 97–4213
  49. Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health. Available at: http://www.oas.samhsa.gov/nsduh.htm. Accessed January 1, 2009.
  50. Shah B, Barnwell B, Bieler G. SUDAAN User's Manual. Version 9.1 ed. Research Triangle Park (NC): Research Triangle Institute; 2005.
  51. Clark HW, Power AK, Le Fauve CE, Lopez EI. Policy and practice implications of epidemiological surveys on co-occurring mental and substance use disorders. J Subst Abuse Treat. 2008;34:3–13
  52. Sterk CE, Theall KP, Elifson KW. Who's getting the message? Intervention group response rates among women who inject drugs and/or smoke crack cocaine. Prev Med. 2003;37:119–128
  53. Friedmann PD, McCullough D, Saitz R. Screening and intervention for illicit drug abuse. Arch Intern Med. 2001;161:248–251
  54. McPherson TL, Hersch RK. Brief substance use screening instruments for primary care settings: a review. J Subst Abuse Treat. 2000;18:193–202
  55. In:  Harrison L,  Huges A editor. The validity of self-reported drug use: improving the accuracy of survey estimates. NIDA Research Monograph 167, NIH Publication No. 97–4147. Rockville (MD): National Institute on Drug Use; 1997;
  56. Bush TL, Miller SR, Golden AL, Hale WE. Self-report and medical record report agreement of selected medical conditions in the elderly. Am J Public Health. 1989;79:1554–1556
  57. Paganini-Hill A, Chao A. Accuracy of recall of hip fracture, heart attack, and cancer: a comparison of postal survey data and medical records. Am J Epidemiol. 1993;138:101–106
  58. Madow WG. Net differences in interview data on chronic conditions and information derived from medical records. Vital Health Stat. 1973;57:1–58
  59. Han B, Gfroerer JC, Colliver JD, Penne MA. Substance use disorder among older adults in the United States in 2020. Addiction. 2009;104:88–96
  60. Johnson RA, Gerstein DR. Initiation of use of alcohol, cigarettes, marijuana, cocaine, and other substances in US birth cohorts since 1919. Am J Public Health. 1998;88:27–33

PII: S1047-2797(10)00004-9

doi: 10.1016/j.annepidem.2010.01.003

Annals of Epidemiology
Volume 20, Issue 4 , Pages 289-297 , April 2010

Article Tools